VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_20-vv-00736 Package ID: USCOURTS-cofc-1_20-vv-00736 Petitioner: Barbara Glover Filed: 2020-06-19 Decided: 2022-08-24 Vaccine: influenza Vaccination date: 2018-10-18 Condition: transverse myelitis Outcome: compensated Award amount USD: 70000 AI-assisted case summary: Barbara Glover filed a petition on June 19, 2020, alleging that she developed transverse myelitis (TM) as a result of an influenza vaccine administered on October 18, 2018. The respondent, the Secretary of Health and Human Services, denied that the vaccine caused Ms. Glover's TM or any other injury. The parties reached a stipulation for compensation, which the Special Master adopted. As part of the stipulation, Ms. Glover was awarded a lump sum of $70,000, representing compensation for all damages. The parties agreed to this stipulation to resolve the case, with the respondent maintaining its denial of causation. The public decision does not describe the onset of symptoms, specific clinical details, diagnostic tests, treatments, or expert witnesses. The decision was issued by Special Master Nora Beth Dorsey on August 24, 2022. Theory of causation field: Petitioner Barbara Glover alleged that an influenza vaccine administered on October 18, 2018, caused her to develop transverse myelitis (TM). The influenza vaccine is listed on the Vaccine Injury Table. Respondent denied causation. The parties reached a stipulation for compensation, and the Special Master adopted the stipulation. Petitioner was awarded $70,000. The public decision does not detail the specific mechanism of injury, expert testimony, or other clinical information beyond the alleged condition and vaccine. Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_20-vv-00736-0 Date issued/filed: 2022-09-19 Pages: 7 Docket text: PUBLIC DECISION (Originally filed: 8/24/2022) regarding 53 DECISION Stipulation. Signed by Special Master Nora Beth Dorsey. (kis) Service on parties made. -------------------------------------------------------------------------------- Case 1:20-vv-00736-UNJ Document 57 Filed 09/19/22 Page 1 of 7 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS Filed: August 24, 2022 * * * * * * * * * * * * * * * * * * * BARBARA GLOVER, * UNPUBLISHED * Petitioner, * No. 20-736V * v. * Special Master Dorsey * SECRETARY OF HEALTH * Decision Based on Stipulation; Influenza AND HUMAN SERVICES, * (“Flu”) Vaccine; Transverse Myelitis * (“TM”). Respondent. * * * * * * * * * * * * * * * * * * * * * Leigh Finfer, Muller Brazil, LLP, Dresher, PA, for Petitioner. Mallori Browne Openchowski, U.S. Department of Justice, Washington, DC, for Respondent. DECISION BASED ON STIPULATION1 On June 19, 2020, Barbara Glover (“Petitioner”) filed a petition in the National Vaccine Injury Program2 alleging that as the result of an influenza (“flu”) vaccine administered on October 18, 2018, she developed transverse myelitis (“TM”). Petition at Preamble (ECF No. 1). On August 23, 2022, the parties filed a stipulation recommending an award of compensation to Petitioner. Stipulation (ECF No. 52). Respondent denies that the flu vaccine caused Petitioner’s alleged TM or any other injury. Nevertheless, the parties agree to the joint 1 Because this Decision contains a reasoned explanation for the action in this case, the undersigned is required to post it on the United States Court of Federal Claims’ website in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the Internet. In accordance with Vaccine Rule 18(b), petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, the undersigned agrees that the identified material fits within this definition, the undersigned will redact such material from public access. 2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-10 to -34 (2012) (“Vaccine Act” or “the Act”). All citations in this Decision to individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa. 1 Case 1:20-vv-00736-UNJ Document 57 Filed 09/19/22 Page 2 of 7 stipulation, attached hereto as Appendix A. The undersigned finds the stipulation reasonable and adopts it as the decision of the Court in awarding damages, on the terms set forth therein. The parties stipulate that Petitioner shall receive the following compensation: (1) A lump sum of $70,000 in the form of a check payable to Petitioner, representing compensation for all damages that would be available under 42 U.S.C. § 300aa- 15(a). Stipulation at ¶ 8. The undersigned approves the requested amount for Petitioner’s compensation. Accordingly, an award should be made consistent with the stipulation. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of Court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ stipulation.3 IT IS SO ORDERED. s/Nora B. Dorsey Nora B. Dorsey Special Master 3 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of notice renouncing the right to seek review. 2 Case 1:20-vv-00736-UNJ Document 57 Filed 09/19/22 Page 3 of 7 IN THE UNITED STATES COURT OF FEDERAL CLAIMS OFFICE OF SPECIAL MASTERS BARBARA GLOVBR, Petitioner, No. 20-736V Special Master Dorsey v. SECRETARY OF HEALTH AND HUMAN SERVICES, Respondent STIPULATION The parties hereby stipulate to the following matters: 1. Petitioner, Batbara Glover, filed a petition for vaccine compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. § 300aa-10 to 34 (the "Vaccine Program''). The petition seeks compensation for injuries allegedly related to petitioner's receipt of the influenza ("flu") vaccine, which vaccine is contained in the Vaccine Injury Table (the "Table"), 42 C.F.R. § 100.3 (a). 2. Petitioner received a flu vaccine on or about October 18, 2018. 3. The vaccine was administered within the United States. 4. Petitioner alleges that the :flu immunization she received on or about October 18, 2018 caused her to develop transverse myelitis (''TMj, and further alleges that she suffered the residual effects of this injury for more than six months. S. Petitioner represents that there bu � no prior award or settlement of a civil action for damages on her behalf as a result of her condition. 6. Respondent denies that the :flu vaccine caused petitioner's alleged TM or IJlY other injury, and further denies that her current disabilities are a sequela of a vaccine-related injury. Page 1 ofS Case 1:20-vv-00736-UNJ Document 57 Filed 09/19/22 Page 4 of 7 Case 1:20-vv-00736-UNJ Document 57 Filed 09/19/22 Page 5 of 7 Case 1:20-vv-00736-UNJ Document 57 Filed 09/19/22 Page 6 of 7 Case 1:20-vv-00736-UNJ Document 57 Filed 09/19/22 Page 7 of 7